Compositions and methods for glucose transport inhibition

Patent metadata

Field	Value
Publication number	US-10000443-B2
Application number	US-201514935902-A
Country	US
Kind code	B2
Filing date	Nov 9, 2015
Priority date	Mar 24, 2010
Publication date	Jun 19, 2018
Grant date	Jun 19, 2018

Abstract

Glucose deprivation is an attractive strategy in cancer research and treatment. Cancer cells upregulate glucose uptake and metabolism for maintaining accelerated growth and proliferation rates. Specifically blocking these processes is likely to provide new insights to the role of glucose transport and metabolism in tumorigenesis, as well as in apoptosis. As solid tumors outgrow the surrounding vasculature, they encounter microenvironments with a limited supply of nutrients leading to a glucose deprived environment in some regions of the tumor. Cancer cells living in the glucose deprived environment undergo changes to prevent glucose deprivation-induced apoptosis. Knowing how cancer cells evade apoptosis induction is also likely to yield valuable information and knowledge of how to overcome the resistance to apoptosis induction in cancer cells. Disclosed herein are novel anticancer compounds that inhibit basal glucose transport, resulting in tumor suppression and new methods for the study of glucose deprivation in animal cancer research.

First claim

What is claimed is:

1. A compound of formula (IV):

wherein R 1 is selected from the group consisting of hydrogen, halo, alkyl, benzyl, amino, nitro, and cyano;
wherein R 2 is selected from the group consisting of benzyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4-, and 3,5-dihydroxyphenyl, 2,3,4-, 2,3,5-, 2,3,6-, and 3,4,5-trihydroxyphenyl, 2,3,4,5- and 2,3,4,6-tetrahydroxyphenyl, perhydroxyphenyl, 2-amino-5-hydroxyphenyl, 2-cyano-5-hydroxyphenyl, 2-fluoro-5-hydroxyphenyl, 2-chloro-5-hydroxyphenyl, 2-chloro-3-hydroxyphenyl, 2-bromo-5-hydroxyphenyl, 2-carboxy-5-hydroxyphenyl, 2-keto-5-hydroxyphenyl, 2-alkoxy-5-hydroxyphenyl, and 2-alkyl-5-hydroxyphenyl;
wherein R 3 is selected from the group consisting of benzyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4-, and 3,5-dihydroxyphenyl, 2,3,4-, 2,3,5-, 2,3,6-, and 3,4,5-trihydroxyphenyl, 2,3,4,5- and 2,3,4,6-tetrahydroxyphenyl, perhydroxyphenyl, 2-amino-5-hydroxyphenyl, 2-cyano-5-hydroxyphenyl, 2-fluoro-5-hydroxyphenyl, 2-chloro-5-hydroxyphenyl, 2-chloro-3-hydroxyphenyl, 2-bromo-5-hydroxyphenyl, 2-carboxy-5-hydroxyphenyl, 2-keto-5-hydroxyphenyl, 2-alkoxy-5-hydroxyphenyl, and 2-alkyl-5-hydroxyphenyl;
or a salt thereof.

2. The compound of claim 1 , wherein
R 1 is chlorine;
R 2 is 2-bromo-5-hydroxyphenyl; and
R 3 is 2-bromo-5-hydroxyphenyl.

3. The compound of claim 1 , wherein
R 1 is chlorine;
R 2 is 2-methyl-5-hydroxyphenyl; and
R 3 is 2-methyl-5-hydroxyphenyl.

4. The compound of claim 1 , wherein
R 1 is chlorine;
R 2 is 2-chloro-5-hydroxyphenyl; and
R 3 is 2-chloro-5-hydroxyphenyl.

5. The compound of claim 1 , wherein the compound is selected from any one of:

or a salt thereof.

Assignees

• Univ Ohio

Inventors

• Chen Xiaozhuo
• Bergmeier Stephen

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• C07C43/23 Primary

  containing hydroxy or O-metal groups · CPC title

• C07C211/48

  N-alkylated amines · CPC title

• A61K45/06

  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title

• A61K31/09

  having two or more such linkages · CPC title